SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shukra Pharmaceuticals informs about separate meeting of independent directors

06 Mar 2026 Evaluate
Shukra Pharmaceuticals has informed that a separate meeting of the Independent Directors of the company will be held on Monday, 16th March, 2026 at the Registered Office of the Company to transact the following business: 1) To review the performance of Non-Independent Directors and the Board as a whole. 2) To Review the performance of the Chairman of the Company. 3) To access the Quantity, Quality and timeliness of flow of information. 4) Any other business with the permission of the chair. 

The above information is a part of company’s filings submitted to BSE.

Shukra Pharma Share Price

30.28 -1.59 (-4.99%)
12-May-2026 14:19 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1859.10
Dr. Reddys Lab 1277.70
Cipla 1303.00
Zydus Lifesciences 935.40
Lupin 2265.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×